- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
PATHOLOGICAL THERAPEUTIC EFFECTS OF PREOPERATIVE SYSTEMIC CHEMOTHERAPY ASSOCIATED WITH BIOMARKERS FOR PRIMARY BREAST CANCER
-
- SENUMA KOJI
- DEPARTMENT OF BREAST AND ENDOCRINE SURGERY, JUNETNDO UNIVERSITY FACULTY OF MEDICINE
-
- MIURA KAYO
- DEPARTMENT OF BREAST AND ENDOCRINE SURGERY, JUNETNDO UNIVERSITY FACULTY OF MEDICINE
-
- MIURA HIROYOSHI
- DEPARTMENT OF BREAST AND ENDOCRINE SURGERY, JUNETNDO UNIVERSITY FACULTY OF MEDICINE
-
- HORIMOTO YOSHIYA
- DEPARTMENT OF BREAST AND ENDOCRINE SURGERY, JUNETNDO UNIVERSITY FACULTY OF MEDICINE
-
- NAKAI KATSUYA
- DEPARTMENT OF BREAST AND ENDOCRINE SURGERY, JUNETNDO UNIVERSITY FACULTY OF MEDICINE
-
- SHIMADA SATOKO
- DEPARTMENT OF BREAST AND ENDOCRINE SURGERY, JUNETNDO UNIVERSITY FACULTY OF MEDICINE
-
- ARAKAWA ATSUSHI
- DEPARTMENT OF HUMAN PATHOLOGY, JUNETNDO UNIVERSITY FACULTY OF MEDICINE
-
- SONOUE HIROSHI
- DEPARTMENT OF HUMAN PATHOLOGY, JUNETNDO UNIVERSITY FACULTY OF MEDICINE
-
- SAITO MITSUE
- DEPARTMENT OF BREAST AND ENDOCRINE SURGERY, JUNETNDO UNIVERSITY FACULTY OF MEDICINE
Bibliographic Information
- Other Title
-
- 術前化学療法を施行した原発性乳癌の組織学的治療効果と関連因子の検討
- ジュツゼン カガク リョウホウ オ シコウ シタ ゲンパツセイ ニュウガン ノ ソシキガクテキ チリョウ コウカ ト カンレン インシ ノ ケントウ
Search this article
Description
Objective : Preoperative systemic chemotherapy (PSC) has become part of the standard treatment for locally advanced primary breast cancer. The aim of this study was to examine the efficacy of PSC for locally advanced primary breast cancer regarding the association of pathological response with certain biomarkers. Materials : The records of patients treated for breast cancer at Juntendo University Hospital from January 2006 to August 2008 were reviewed from a prospectively collected database. A total of 144 patients diagnosed with primary breast cancer, whose specimens were investigated by immunostaining, underwent PSC during this period. Methods : A comparison was made between the pathological complete response (pCR) and hormonal receptor, human epidermal growth factor receptor type 2 (HER2), Ki-67 and topoisomerase IIα (Topo IIα). The correlations of HER2 with Topo IIα, hormonal receptor and intrinsic subtypes were also studied. Results : pCR was achieved in 16 cases (11%). The rate of pCR was significantly higher in hormonal status-negative cases than in hormonal status-positive ones. pCR in HER2-positive cases, however, showed no significant difference compared with that in negative ones. The rate of pCR was significantly higher in high-Ki-67 cases than in low-Ki-67 ones. pCR showed no significant difference between the high-Topo IIα and low-Topo IIα cases. No correlation was observed in HER2 with Topo IIα and hormonal status. In terms of intrinsic subtype classification, pCR in HER2 type and triple-negative type (i. e. estrogen-negative, progesterone-negative and HER2-negative) was significantly higher in luminal A/ B types. Conclusions : We showed that the efficacy of PSC was affected by not only hormonal-negative and high-Ki-67 status, but also HER2 type and triple-negative type.
Journal
-
- Juntendo Medical Journal
-
Juntendo Medical Journal 59 (3), 251-259, 2013
The Juntendo Medical Society